Thus, TNF-α and IL-6 may lead to limited PCT production in patients with highly active HL, which is not sufficient to cause clinically significant serum PCT elevation (≥0.5 ng/mL), except from “extreme” cases with advanced disease, presence of B symptoms and highly elevated inflammatory markers, as the single case observed in our series. Here, IL6 is linked to Hodgkins lymphoma.